178 related articles for article (PubMed ID: 9469691)
21. Comparison of cefoxitin, cefotetan, and ampicillin/sulbactam as prophylaxis for polymicrobial infection in mice.
Brook I
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S376-7. PubMed ID: 7548603
[No Abstract] [Full Text] [Related]
22. Antibiotic therapy in intra-abdominal infections--a review on randomised clinical trials.
Holzheimer RG; Dralle H
Eur J Med Res; 2001 Jul; 6(7):277-91. PubMed ID: 11485888
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of ampicillin-sulbactam versus that of cefoxitin for treatment of Escherichia coli infections in a rat intra-abdominal abscess model.
Rice LB; Carias LL; Shlaes DM
Antimicrob Agents Chemother; 1993 Mar; 37(3):610-2. PubMed ID: 8460928
[TBL] [Abstract][Full Text] [Related]
24. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
Harbarth S; Harris AD; Carmeli Y; Samore MH
Clin Infect Dis; 2001 Nov; 33(9):1462-8. PubMed ID: 11588690
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness study comparing cefoperazone-sulbactam to a three-drug combination for treating intraabdominal infections in an Indian health-care setting.
Kochhar P; Suvarna V; Duttagupta S; Sarkar S
Value Health; 2008 Mar; 11 Suppl 1():S33-8. PubMed ID: 18387065
[TBL] [Abstract][Full Text] [Related]
26. Sulbactam-containing beta-lactamase inhibitor combinations.
Akova M
Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():185-8. PubMed ID: 18154545
[TBL] [Abstract][Full Text] [Related]
27. Sulbactam/ampicillin versus cefoxitin for uncomplicated and complicated acute pelvic inflammatory disease.
Hemsell DL; Heard MC; Hemsell PG; Nobles BJ
Drugs; 1988; 35 Suppl 7():39-42. PubMed ID: 3220008
[TBL] [Abstract][Full Text] [Related]
28. Perioperative antibiotic use in high-risk penetrating hollow viscus injury: a prospective randomized, double-blind, placebo-control trial of 24 hours versus 5 days.
Kirton OC; O'Neill PA; Kestner M; Tortella BJ
J Trauma; 2000 Nov; 49(5):822-32. PubMed ID: 11086771
[TBL] [Abstract][Full Text] [Related]
29. Early postpartum endometritis. Randomized comparison of ampicillin/sulbactam vs. ampicillin, gentamicin and clindamycin.
Resnik E; Harger JH; Kuller JA
J Reprod Med; 1994 Jun; 39(6):467-72. PubMed ID: 7932402
[TBL] [Abstract][Full Text] [Related]
30. Use of ampicillin-sulbactam before and after formulary inclusion.
Koch KE; Taylor MR
Am J Hosp Pharm; 1991 Jul; 48(7):1492-6. PubMed ID: 1882880
[TBL] [Abstract][Full Text] [Related]
31. [Unasyn in severe hospital infections].
Sechser T; Hatala M; Svácek J; Modr Z
Cas Lek Cesk; 1991 May; 130(14):438-44. PubMed ID: 2070390
[TBL] [Abstract][Full Text] [Related]
32. Bactericidal activity of low-dose ceftizoxime plus metronidazole compared with cefoxitin and ampicillin-sulbactam.
Freeman CD; Nightingale CH; Nicolau DP; Belliveau PP; Tessier PR; Fu Q; Xuan DW; Quintiliani R
Pharmacotherapy; 1994; 14(2):185-90. PubMed ID: 8197037
[TBL] [Abstract][Full Text] [Related]
33. Rational antibiotic therapy and the position of ampicillin/sulbactam.
Lode HM
Int J Antimicrob Agents; 2008 Jul; 32(1):10-28. PubMed ID: 18539004
[TBL] [Abstract][Full Text] [Related]
34. Effect of beta-lactamase inhibitors on minimum inhibitory concentration of ampicillin and amoxicillin for Staphylococcus aureus strains.
Paniagua GL; Monroy E; García O; Vaca S
Rev Latinoam Microbiol; 1998; 40(3-4):128-34. PubMed ID: 10932741
[TBL] [Abstract][Full Text] [Related]
35. Prospective, randomized, study of ampicillin-sulbactam versus moxifloxacin monotherapy for the treatment of community-acquired complicated intra-abdominal infections.
Chen CW; Ming CC; Ma CJ; Shan YS; Yeh YS; Wang JY
Surg Infect (Larchmt); 2013 Aug; 14(4):389-96. PubMed ID: 23859673
[TBL] [Abstract][Full Text] [Related]
36. Ampicillin/sulbactam versus cefotetan for the prevention of infection following cesarean delivery in high-risk patients: a randomized double-blind trial.
Bracero LA
Gynecol Obstet Invest; 1997; 44(1):21-5. PubMed ID: 9251949
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and cost of ampicillin-sulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections.
McKinnon PS; Neuhauser MM
Pharmacotherapy; 1999 Jun; 19(6):724-33. PubMed ID: 10391418
[TBL] [Abstract][Full Text] [Related]
38. Treating foot infections in diabetic patients: a randomized, multicenter, open-label trial of linezolid versus ampicillin-sulbactam/amoxicillin-clavulanate.
Lipsky BA; Itani K; Norden C;
Clin Infect Dis; 2004 Jan; 38(1):17-24. PubMed ID: 14679443
[TBL] [Abstract][Full Text] [Related]
39. Antibiotic prophylaxis in transurethral surgery: a comparison of sulbactam-ampicillin and cefoxitin.
Dørflinger T; Madsen PO
Infection; 1985; 13(2):66-9. PubMed ID: 2987133
[TBL] [Abstract][Full Text] [Related]
40. Economic impact of palifermin on the costs of hospitalization for autologous hematopoietic stem-cell transplant: analysis of phase 3 trial results.
Elting LS; Shih YC; Stiff PJ; Bensinger W; Cantor SB; Cooksley C; Spielberger R; Emmanoulides C
Biol Blood Marrow Transplant; 2007 Jul; 13(7):806-13. PubMed ID: 17580258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
